CDNA Trade on Jun 23, 2021 13:54 from MichaelBLe: Tradervue User Stock Trades.

CDNA has strong earnings and sales growth the last 4 quarters. Posting triple digit earnings and very strong consistent sales growth. This isn't a biotech stock relying on FDA approvals, so I am comfortable with taking this name long. Only about 6% off from ATHs. Has 3 IBD mutual fund's in this name.

What I like particularly about this chart is the inside weekly candle it made last week. It's on higher volume but basically closed as an even doji. A quick breather just below key pivot isn't ideal but it's better than going straight up.

6-24
9:07AM
This name had a gap up along with a lot of other stocks. It filled gap but unable to bounce. The consolidation was too quick imo. It was iffy position to start with from the jump. And I knew it. Tied up 10% equity and could have been used on a different name.